Issues and Prospects of microRNA-Based Biomarkers in Blood and Other Body Fluids
Open Access
Abstract
Cell-free circulating microRNAs (miRNAs) in the blood are good diagnostic biomarker candidates for various physiopathological conditions, including cancer, neurodegeneration, diabetes and other diseases. Since their discovery in 2008 as blood biomarkers, the field has expanded rapidly with a number of important findings. Despite the initial optimistic views of their potential for clinical application, there are currently no circulating miRNA-based diagnostics in use. In this article, we review the status of circulating miRNAs, examine different analytical approaches, and address some of the challenges and opportunities.Keywords
This publication has 186 references indexed in Scilit:
- Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker LevelsPLOS ONE, 2013
- Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical BindingCell, 2013
- Cell-free microRNAs: potential biomarkers in need of standardized reportingFrontiers in Genetics, 2013
- Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomesFrontiers in Molecular Neuroscience, 2013
- Blood serum miRNA: Non-invasive biomarkers for Alzheimer's diseaseExperimental Neurology, 2012
- Plasma Components Affect Accuracy of Circulating Cancer-Related MicroRNA QuantitationThe Journal of Molecular Diagnostics, 2012
- Profiling of Short RNAs Using Helicos Single-Molecule Sequencing2011
- Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarctionBiochemical and Biophysical Research Communications, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007